189 related articles for article (PubMed ID: 32635183)
21. Analysis of the miRNA-mRNA-lncRNA networks in ER+ and ER- breast cancer cell lines.
Wu Q; Guo L; Jiang F; Li L; Li Z; Chen F
J Cell Mol Med; 2015 Dec; 19(12):2874-87. PubMed ID: 26416600
[TBL] [Abstract][Full Text] [Related]
22. Serum-based six-miRNA signature as a potential marker for EC diagnosis: Comparison with TCGA miRNAseq dataset and identification of miRNA-mRNA target pairs by integrated analysis of TCGA miRNAseq and RNAseq datasets.
Sharma P; Saraya A; Sharma R
Asia Pac J Clin Oncol; 2018 Oct; 14(5):e289-e301. PubMed ID: 29380534
[TBL] [Abstract][Full Text] [Related]
23. Widespread estrogen-dependent repression of micrornas involved in breast tumor cell growth.
Maillot G; Lacroix-Triki M; Pierredon S; Gratadou L; Schmidt S; Bénès V; Roché H; Dalenc F; Auboeuf D; Millevoi S; Vagner S
Cancer Res; 2009 Nov; 69(21):8332-40. PubMed ID: 19826037
[TBL] [Abstract][Full Text] [Related]
24. Integrated analysis of mRNA and miRNA profiles revealed the role of miR-193 and miR-210 as potential regulatory biomarkers in different molecular subtypes of breast cancer.
Evangelista AF; Oliveira RJ; O Silva VA; D C Vieira RA; Reis RM; C Marques MM
BMC Cancer; 2021 Jan; 21(1):76. PubMed ID: 33461524
[TBL] [Abstract][Full Text] [Related]
25. A Competing Endogenous RNA Network Reveals Novel lncRNA, miRNA and mRNA Biomarkers With Diagnostic and Prognostic Value for Early Breast Cancer.
Luo ZB; Lai GE; Jiang T; Cao CL; Peng T; Liu FE
Technol Cancer Res Treat; 2020; 19():1533033820983293. PubMed ID: 33371806
[TBL] [Abstract][Full Text] [Related]
26. Integrative analysis reveals disrupted pathways regulated by microRNAs in cancer.
Wilk G; Braun R
Nucleic Acids Res; 2018 Feb; 46(3):1089-1101. PubMed ID: 29294105
[TBL] [Abstract][Full Text] [Related]
27. Screening and Bioinformatics Analysis of Competitive Endogenous RNA Regulatory Network --Related to Circular RNA in Breast Cancer.
Wang T; Zhang Y; He Y; Liu Y; Qi P
Biomed Res Int; 2021; 2021():5575286. PubMed ID: 34545330
[TBL] [Abstract][Full Text] [Related]
28. Gene co-expression network approach for predicting prognostic microRNA biomarkers in different subtypes of breast cancer.
Adhami M; MotieGhader H; Haghdoost AA; Afshar RM; Sadeghi B
Genomics; 2020 Jan; 112(1):135-143. PubMed ID: 30735795
[TBL] [Abstract][Full Text] [Related]
29. Integrated microRNA and mRNA signatures associated with survival in triple negative breast cancer.
Cascione L; Gasparini P; Lovat F; Carasi S; Pulvirenti A; Ferro A; Alder H; He G; Vecchione A; Croce CM; Shapiro CL; Huebner K
PLoS One; 2013; 8(2):e55910. PubMed ID: 23405235
[TBL] [Abstract][Full Text] [Related]
30. Comprehensive expression analysis of miRNA in breast cancer at the miRNA and isomiR levels.
Wu X; Zeng R; Wu S; Zhong J; Yang L; Xu J
Gene; 2015 Feb; 557(2):195-200. PubMed ID: 25523096
[TBL] [Abstract][Full Text] [Related]
31. Breast tissue-based microRNA panel highlights microRNA-23a and selected target genes as putative biomarkers for breast cancer.
Eissa S; Matboli M; Shehata HH
Transl Res; 2015 Mar; 165(3):417-27. PubMed ID: 25445205
[TBL] [Abstract][Full Text] [Related]
32. Comprehensive analysis of the aberrantly expressed lncRNA‑associated ceRNA network in breast cancer.
Tuersong T; Li L; Abulaiti Z; Feng S
Mol Med Rep; 2019 Jun; 19(6):4697-4710. PubMed ID: 31059025
[TBL] [Abstract][Full Text] [Related]
33. Identification of core miRNAs and regulatory pathways in breast cancer by integrated bioinformatics analysis.
Feng H; Song Z
Mol Omics; 2021 Apr; 17(2):277-287. PubMed ID: 33462573
[TBL] [Abstract][Full Text] [Related]
34. ATF-3/miR-590/GOLPH3 signaling pathway regulates proliferation of breast cancer.
Song Q; Chen Q; Wang Q; Yang L; Lv D; Jin G; Liu J; Li B; Fei X
BMC Cancer; 2018 Mar; 18(1):255. PubMed ID: 29534690
[TBL] [Abstract][Full Text] [Related]
35. Identification of Key Prognostic-Related miRNA-mRNA Pairs in the Progression of Endometrial Carcinoma.
Dong Y; Zhang T; Li X; Yu F; Yu H; Shao S
Gynecol Obstet Invest; 2022; 87(1):12-21. PubMed ID: 35081534
[TBL] [Abstract][Full Text] [Related]
36. Comprehensive analysis of differentially expressed profiles of lncRNAs, mRNAs, and miRNAs in laryngeal squamous cell carcinoma in order to construct a ceRNA network and identify potential biomarkers.
Kong X; Qi J; Yan Y; Chen L; Zhao Y; Fang Z; Fan J; Liu M; Liu Y
J Cell Biochem; 2019 Oct; 120(10):17963-17974. PubMed ID: 31127661
[TBL] [Abstract][Full Text] [Related]
37. Construction of an initial microRNA regulation network in breast invasive carcinoma by bioinformatics analysis.
Yin Y; Shen C; Xie P; Cheng Z; Zhu Q
Breast; 2016 Apr; 26():1-10. PubMed ID: 27017236
[TBL] [Abstract][Full Text] [Related]
38. Circular RNA hsa_circ_0000376 Participates in Tumorigenesis of Breast Cancer by Targeting miR-1285-3p.
Peng Z; Xu B; Jin F
Technol Cancer Res Treat; 2020; 19():1533033820928471. PubMed ID: 32462972
[TBL] [Abstract][Full Text] [Related]
39. miRNA expression profiling of hereditary breast tumors from BRCA1- and BRCA2-germline mutation carriers in Brazil.
Pessôa-Pereira D; Evangelista AF; Causin RL; da Costa Vieira RA; Abrahão-Machado LF; Santana IVV; da Silva VD; de Souza KCB; de Oliveira-Silva RJ; Fernandes GC; Reis RM; Palmero EI; Marques MMC
BMC Cancer; 2020 Feb; 20(1):143. PubMed ID: 32087690
[TBL] [Abstract][Full Text] [Related]
40. Identification of microRNA biomarkers in the blood of breast cancer patients based on microRNA profiling.
Zhang K; Wang YW; Wang YY; Song Y; Zhu J; Si PC; Ma R
Gene; 2017 Jul; 619():10-20. PubMed ID: 28359916
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
